Apr 27, 2023 · 33m · no-priors

No Priors Ep. 14 | With Sarah Guo and Elad Gil

Elad Gil · 18m spoken Sarah Guo · 12m spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In this audience Q&A episode of No Priors, hosts Sarah Guo and Elad Gil analyze the rapid evolution of open-source AI models, the rise of autonomous agent architectures, the economic risks of premature regulation, and the best startup investment opportunities across the AI landscape.

Statements from this episode (13)

Assertion Supported
Guo: No open-source model matches GPT-3.5, GPT-4, or Claude quality
“So there's nothing out there today in open source that is like GPT four, three, five or anthropic cloud quality, right? So there is a, there's one player out in front and that's open AI”
Sarah Guo Apr 27, 2023 ▶ 0:32
Insight
Guo: Retraining the same size model is 5x cheaper on the second run
“It's going to be five X cheaper to train the same size model the second time around, like, once you've made your mistakes and know what you're doing.”
Sarah Guo Apr 27, 2023 ▶ 1:14
Prediction Held up
Guo: An open-source model matching GPT-3.5 will arrive within a year
“Like if I were a betting woman and I am, I bet there's a three, five level model in the open source ecosystem within a year.”
Sarah Guo Apr 27, 2023 ▶ 1:36
Insight
Guo: Autonomous agents orchestrate LLM loops without changing model architecture
“The basic idea is to orchestrate LMs in this like iterative loop towards some high level goal. Where they're doing planning, and if memory, and prioritization, reflection, and so you're not necessarily changing the architecture of the LLM itself, but this orch…”
Sarah Guo Apr 27, 2023 ▶ 2:59
Prediction Not checkable as stated
Gil: 2024 election will be the pivotal moment driving AI regulation
“The big pivot point for regulation may actually come during the 20, 24 election. Because I think that's the moment that people will show examples of AI being used to influence the election or influence voting behavior, just like ads influence voting behavior, …”
Elad Gil Apr 27, 2023 ▶ 8:51
Insight
Guo: AI alignment research cannot be separated from capability research
“Alignment research is very tied to capability research, right? And so it's sort of impossible to be like, we're going to stop making any progress on research. But figure out how to control this stuff.”
Sarah Guo Apr 27, 2023 ▶ 11:00
Prediction Not checkable as stated
Gil: AI poses no existential threat to humanity within ten years
“So you need physical form for the AI in order for it to truly be an existential threat. And that's why if I were to focus on an area, it'd probably be robotics or something like that, because that's where you suddenly give physical form to something. And if yo…”
Elad Gil Apr 27, 2023 ▶ 12:25
Assertion Supported
Guo: Midjourney has a completely investor-free cap table
“Like any investor that claims they knew image generation From text was a killer use case, like, a year or two ago, besides you, is just empirically wrong, given David's completely investor-free cap table and amazing business, right, so.”
Sarah Guo Apr 27, 2023 ▶ 15:52
Opinion
Gil: Elon Musk's AI moratorium call was self-serving given his LLM startup
“Musk was asking for a six month moratorium on progress, which seems to me very self-serving if you're simultaneously starting an LLM company, you know.”
Elad Gil Apr 27, 2023 ▶ 20:01
Prediction Not checkable as stated
Gil: AI value capture will likely be 80% incumbents, 20% startups
“And it feels like in this wave, it's probably eighty-twenty again, right? It's probably, Google will probably become a player, right? OpenAI is closely aligned with Microsoft. And then, you know Salesforce with AI is probably Salesforce, right? It probably isn…”
Elad Gil Apr 27, 2023 ▶ 23:15
Prediction Not checkable as stated
Gil: AI will be adopted fastest in healthcare operations and delivery
“Usually I think the places in healthcare where this will really get applied fast. Is on the more operational or services intensive related side. It's healthcare delivery. It's lowering the cost of a doctor visit or telemedicine. It's making payments easier and…”
Elad Gil Apr 27, 2023 ▶ 24:59
Assertion Contradicted
Gil: No major drug-developing biotech founded since late 1980s hit $30B-$50B
“The last time a biotech company hit, I don't know what it is, 3040, fifty billion dollars in market cap, something like that. The last year such a thing was founded was in the late eighties. So it's been at this point, what is that? 35, 40 years without a new …”
Elad Gil Apr 27, 2023 ▶ 27:40
Assertion Supported
Gil: Top four or five tech companies equal the entire biopharma market cap
“If you add up the top four or five tech companies, their market cap equals the entire industry for biopharma.”
Elad Gil Apr 27, 2023 ▶ 28:15
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.